Volitionrx Ltd (VNRX)

Trade VNRX now with
11/10/2017 7:32:27 AM Singapore Volition Signs MoU National Taiwan University To Conduct Two Large Clinical Studies
9/14/2017 8:07:02 AM VolitionRx Secures Four Additional Patents Relating To Its Proprietary Nu.Q Platform
5/11/2017 6:35:53 AM VolitionRx Q1 Net Loss $3.35 Mln Or $0.13/shr Vs Loss Of $2.49 Mln Or $0.13/shr Last Year
4/21/2017 8:27:31 AM VolitionRx Opens New Research And Development Facility This Week
4/11/2017 7:02:45 AM VolitionRx Appoints David Vanston As CFO, Effective April 10
3/20/2017 6:32:07 AM VolitionRx Limited Announces Formation Of Volition America
3/10/2017 6:34:14 AM VolitionRx FY Net Loss $11.9 Mln Or $0.52/Shr Vs Loss Of $9.5 Mln Or $0.54/Shr Last Year
11/10/2016 6:36:07 AM VolitionRx Q3 Net Loss $3.48 Mln Or $0.15/shr Vs. Net Loss $2.96 Mln Or $0.16/shr Prior Year
10/26/2016 6:34:54 AM VolitionRx Limited Announces Acquisition Of New Belgian Facility
10/5/2016 12:24:37 PM VolitionRx Closes Public Offering Of 2.25 Mln Common Shares At $5/share
9/30/2016 8:47:55 AM VolitionRx Prices Public Offering Of 2.25 Mln Shares At $5.00 Per Share
9/29/2016 4:05:08 PM VolitionRx Announces Proposed Public Offering Of Common Stock
8/11/2016 6:35:10 AM VolitionRx Q2 Loss Per Share $0.13 Vs Loss $0.10 Last Year
6/24/2016 7:01:06 AM VolitionRx Appoints Edward Futcher To Board, Effective June 23
5/12/2016 7:06:15 AM VolitionRx Initiates Clinical Trial To Evaluate NuQ Blood Test For Pancreatic Cancer
4/20/2016 9:10:46 AM VolitionRx Reports Study Results Showing NuQ Blood Test Detects Prostate Cancer Early With Higher Accuracy
4/7/2016 7:13:47 AM VolitionRx Announces CE Marks For Two NuQ Blood Assays For Detection Of Colorectal Cancer
3/18/2016 9:32:23 AM VolitionRx Prices Underwritten Public Offering Of 3.8 Mln Shares At $3.25/shr
3/9/2016 7:14:18 AM VolitionRx Says Preliminary Data Demonstrates 86% Accuracy In Detecting Idiopathic Pulmonary Fibrosis
1/5/2016 7:04:10 AM VolitionRx Reports Jason Terrell's Transition To Full-Time Status As Chief Medical Officer And Head Of U.S. Operations